Next Article in Journal
Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor Modalities
Next Article in Special Issue
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Progress in Small Molecule Drug Development
Previous Article in Journal
Building Cell Selectivity into CPP-Mediated Strategies
Previous Article in Special Issue
Effects of NSAIDs on Differentiation and Function of Human and Murine Osteoclasts – Crucial ‘Human Osteoclastology’

Critical Overview on the Benefits and Harms of Aspirin

School of Medicine, University of East Anglia, Norwich, NR47TJ, UK
Author to whom correspondence should be addressed.
Pharmaceuticals 2010, 3(5), 1491-1506;
Received: 15 March 2010 / Revised: 30 April 2010 / Accepted: 7 May 2010 / Published: 14 May 2010
(This article belongs to the Special Issue Non-Steroidal Anti-Inflammatory Drugs)
Aspirin is widely used internationally for a variety of indications, with the most prominent one being that of cardiovascular disease. However, aspirin has also been proposed as a treatment option in a diverse range of conditions such as diabetes mellitus, cancer prevention, and obstetrics. In our overview, we critically appraise the current evidence from recent systematic reviews and meta-analyses covering the benefits of aspirin across these conditions. We also look at evidence that some patients may not derive benefit due to the concept of aspirin resistance. Aspirin is also associated with the potential for significant harm, principally from haemorrhagic adverse events. We critically appraise the threat of haemorrhagic complications, and weigh up these risks against that of any potential benefit. View Full-Text
Keywords: aspirin; efficacy; adverse events aspirin; efficacy; adverse events
Show Figures

Figure 1

MDPI and ACS Style

Kwok, C.S.; Loke, Y.K. Critical Overview on the Benefits and Harms of Aspirin. Pharmaceuticals 2010, 3, 1491-1506.

AMA Style

Kwok CS, Loke YK. Critical Overview on the Benefits and Harms of Aspirin. Pharmaceuticals. 2010; 3(5):1491-1506.

Chicago/Turabian Style

Kwok, Chun Shing, and Yoon K. Loke 2010. "Critical Overview on the Benefits and Harms of Aspirin" Pharmaceuticals 3, no. 5: 1491-1506.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop